Source:http://linkedlifedata.com/resource/pubmed/id/17879316
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2007-10-1
|
pubmed:abstractText |
Lymphangioma is a disfiguring malformation of early childhood. A mouse lymphangioma model has been established by injecting Freund's incomplete adjuvant (FIA) intraperitoneally, but has not been compared with the human disease. We show that, in accordance with studies from the 1960s, the mouse model represents an oil-granuloma, made up of CD45-positive leukocytes and invaded by blood and lymph vessels. Several markers of lymphatic endothelial cells are expressed in both mouse and human, like CD31, Prox1, podoplanin, and Lyve-1. However, the human disease affects all parts of the lymphovascular tree. We observed convolutes of lymphatic capillaries, irregularly formed collectors with signs of disintegration, and large lymph cysts. We observed VEGFR-2 and -3 expression in both blood vessels and lymphatics of the patients, whereas in mouse VEGFR-2 was confined to activated blood vessels. The experimental mouse FIA model represents a vascularized oil-granuloma rather than a lymphangioma and reflects the complexity of human lymphangioma only partially.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD31,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Freund's Adjuvant,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor...,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1058-8388
|
pubmed:author | |
pubmed:copyrightInfo |
2007 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:volume |
236
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2952-61
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:17879316-Animals,
pubmed-meshheading:17879316-Antigens, CD31,
pubmed-meshheading:17879316-Biological Markers,
pubmed-meshheading:17879316-Disease Models, Animal,
pubmed-meshheading:17879316-Endothelium, Lymphatic,
pubmed-meshheading:17879316-Freund's Adjuvant,
pubmed-meshheading:17879316-Granuloma,
pubmed-meshheading:17879316-Humans,
pubmed-meshheading:17879316-Infant,
pubmed-meshheading:17879316-Lymphangioma,
pubmed-meshheading:17879316-Lymphatic Vessels,
pubmed-meshheading:17879316-Male,
pubmed-meshheading:17879316-Mice,
pubmed-meshheading:17879316-Mice, Inbred BALB C,
pubmed-meshheading:17879316-Vascular Endothelial Growth Factor Receptor-2,
pubmed-meshheading:17879316-Vascular Endothelial Growth Factor Receptor-3
|
pubmed:year |
2007
|
pubmed:articleTitle |
Similarities and differences of human and experimental mouse lymphangiomas.
|
pubmed:affiliation |
Department of Anatomy and Cell Biology, Georg-August-University, Goettingen, Germany.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|